NEW YORK (GenomeWeb News) – The Fred Hutchinson Cancer Research Center will use GenoLogics’ translational research software in its early-detection cancer research programs, the Canadian company said today.
The Canary Foundation, a non-profit charity focused on funding cancer detection research, is providing the center with GenoLogics' Biomedical Informatics software suite.
The software includes five products: BioVault is used to manage biospecimens; BioChronicle is used for managing clinical annotations; BioQuest is designed to enable web access; BioSphere is used to manage studies; and BioSource is used to enable electronic patient questionnaires.
The company said it will collaborate with Hutch to develop an integrated biorepository and biomedical informatics solution to be used in the center’s Translational and Outcomes Research group.
Financial terms of the agreement were not released.